Pittsburgh, PA, United States of America

Ryan Patrick LeGraw

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Arizona State University, Johns Hopkins University. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ryan LeGraw: Innovator in Synthetic Liver Organoids

Introduction

Ryan LeGraw is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of synthetic biology, particularly in the development of liver organoids. His work focuses on creating advanced models that can be used for drug discovery and understanding human liver development.

Latest Patents

Ryan LeGraw holds a patent for "Next generation designer liver organoids and their methods of preparation and use." This patent relates to synthetic liver organoids and outlines methods for utilizing these organoids in various applications. The synthetic liver organoids comprise mature, functional cells found in the human liver, which enhances their utility in research and medical applications.

Career Highlights

Throughout his career, Ryan has worked with prestigious institutions such as Johns Hopkins University and Arizona State University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ryan has collaborated with notable colleagues, including Mo Reza Ebrahimkhani and Samira Kiani. These partnerships have further enriched his research and innovation in synthetic liver organoids.

Conclusion

Ryan LeGraw's work in synthetic liver organoids represents a significant advancement in biomedical research. His innovative approach and dedication to improving drug discovery and liver modeling are commendable.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…